Suppr超能文献

多发性硬化症患者全生命周期的抑郁状况。

Depression in multiple sclerosis across the adult lifespan.

机构信息

Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

Mult Scler. 2021 Oct;27(11):1771-1780. doi: 10.1177/1352458520979304. Epub 2020 Dec 14.

Abstract

OBJECTIVES

The objective of this study is to examine the burden of depressive symptoms across the adult age span in people with multiple sclerosis (MS) and test if the relationship between depressive symptoms and MS characteristics vary across age groups.

METHODS

In analyses of the MS Partners Advancing Technology and Health Solutions (MS PATHS) network of adults with MS, we compared the prevalence of depression in MS PATHS with non-MS controls across age and evaluated for effect modification by age in the association between depressive symptoms and clinical and neuroperformance measures via multivariable-adjusted regression models.

RESULTS

In total, 13,821 individuals with MS were included. The prevalence of depression was higher in MS versus non-MS controls, but was similar between men/women across age. The association between depression and processing speed (PST; for interaction = 0.009) or walking speed ( for interaction = 0.04) varied by age. For example, younger depressed individuals had 0.45 standard deviation (SD) (95% confidence interval (CI) = -0.62, -0.29) worse PST -scores versus non-depressed younger participants, whereas older depressed individuals had 0.20 SD (95% CI = -0.32, -0.08) worse PST -scores versus non-depressed older participants.

CONCLUSION

Depressive symptoms and age should be considered when interpreting measures of walking speed and cognitive function; these findings may have implications for analyses of neuroperformance change.

摘要

目的

本研究旨在考察多发性硬化症(MS)患者成年期抑郁症状的负担,并检验抑郁症状与 MS 特征之间的关系是否因年龄组而异。

方法

在分析多发性硬化症合作伙伴推进技术和健康解决方案(MS PATHS)网络中成年人的数据时,我们比较了 MS PATHS 中与非 MS 对照组在年龄上的抑郁患病率,并通过多变量调整回归模型评估了抑郁症状与临床和神经表现测量值之间的关联在年龄上的交互作用。

结果

共纳入 13821 名 MS 患者。MS 患者的抑郁患病率高于非 MS 对照组,但在不同年龄段的男性/女性中相似。抑郁与处理速度(PST;交互作用 = 0.009)或行走速度(交互作用 = 0.04)之间的关联因年龄而异。例如,与非抑郁的年轻参与者相比,年轻抑郁患者的 PST 评分差 0.45 个标准差(95%置信区间(CI)=-0.62,-0.29),而年龄较大的抑郁患者的 PST 评分差 0.20 个标准差(95% CI = -0.32,-0.08),而非抑郁的老年参与者。

结论

在解释行走速度和认知功能的测量值时,应考虑抑郁症状和年龄;这些发现可能对神经表现变化的分析有影响。

相似文献

1
Depression in multiple sclerosis across the adult lifespan.多发性硬化症患者全生命周期的抑郁状况。
Mult Scler. 2021 Oct;27(11):1771-1780. doi: 10.1177/1352458520979304. Epub 2020 Dec 14.

引用本文的文献

6
Depression and anxiety in multiple sclerosis. Review of a fatal combination.多发性硬化症中的抑郁和焦虑。致命组合的综述。
J Neural Transm (Vienna). 2024 Aug;131(8):847-869. doi: 10.1007/s00702-024-02792-0. Epub 2024 Jun 13.
9
Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis.多发性硬化症患者前驱期的精神共病。
Neurology. 2023 Nov 14;101(20):e2026-e2034. doi: 10.1212/WNL.0000000000207843. Epub 2023 Sep 25.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验